P. Fenaux, C. Chastang, and S. Chevret, A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group, Blood, vol.14, pp.1192-1200, 1999.

M. Sanz, G. Martin, and M. Gonzalez, Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group, Blood, vol.103, issue.4, pp.1237-1243, 2004.
DOI : 10.1182/blood-2003-07-2462

M. Sanz, G. Martin, and C. Rayon, A modified AIDA protocol with anthracyclin based consolidation result in high anti leukemia efficacy and reduced toxicity in newly diagnosed PML/RARalpha positive acute promyelocytic leukemia PETHEMA group, Blood, vol.94, pp.3015-3021, 1999.

M. Tallman, J. Andersen, and C. Schiffer, Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome, Blood, vol.95, pp.90-95, 2000.

S. De-botton, H. Dombret, and M. Sanz, Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia, Blood, vol.92, pp.2712-2727, 1998.

S. Simzar, A. Rotunda, and N. Craft, Scrotal ulceration as a consequence of all-trans-retinoic acid (ATRA) for the treatment of acute promyelocytic leukemia, J Drugs Dermatol, vol.4, pp.231-232, 2005.

S. Frankel, A. Eardley, and G. Heller, All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study, Annals of Internal Medicine, vol.120, issue.4, pp.278-286, 1994.
DOI : 10.7326/0003-4819-120-4-199402150-00004

L. Vahdat, P. Maslak, M. Jr, and W. , Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid, Blood, vol.84, pp.3843-3849, 1994.

P. Von-den-driesch, Sweet's syndrome (acute febrile neutrophilic dermatosis), Journal of the American Academy of Dermatology, vol.31, issue.4, pp.861-865, 1994.
DOI : 10.1016/S0190-9622(94)70215-2

D. Friedman, Idiopathic intracranial hypertension, Current Pain and Headache Reports, vol.17, issue.1, pp.62-68, 2007.
DOI : 10.1007/s11916-007-0024-8

B. Cheson, P. Cassileth, and D. Head, Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia., Journal of Clinical Oncology, vol.8, issue.5, pp.813-819, 1990.
DOI : 10.1200/JCO.1990.8.5.813

D. Dower, The epidemiology of acute promyelocytic leukaemia, Best Practice & Research Clinical Haematology, vol.16, issue.3, pp.357-367, 2003.
DOI : 10.1016/S1521-6926(03)00065-3

G. Avvisati, A. Mele, and M. Stasi, Original article: Epidemiology of acute promyelocytic leukemia in Italy, Annals of Oncology, vol.2, issue.6, pp.405-408, 1991.
DOI : 10.1093/oxfordjournals.annonc.a057974

A. Mele, M. Stasi, and A. Pulsoni, Epidemiology of acute promyelocytic leukemia, Haematologica, vol.80, pp.405-408, 1995.

D. Grimwade, H. Walker, and F. Oliver, The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial, Blood, vol.92, pp.2322-2333, 1998.

E. Estey, P. Thall, H. Kantarjian, S. Pierce, S. Kornblau et al., Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia, Leukemia, vol.11, issue.10, pp.1661-1664, 1997.
DOI : 10.1038/sj.leu.2400783

J. Pedersen-bjergaard and J. Rowley, The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation, Blood, vol.83, pp.2780-2786, 1994.

A. Schaffler, U. Muller-ladner, J. Scholmerich, and C. Buchler, Role of Adipose Tissue as an Inflammatory Organ in Human Diseases, Endocrine Reviews, vol.27, issue.5, pp.449-467, 2006.
DOI : 10.1210/er.2005-0022

M. Konopleva, A. Mikhail, and Z. Estov, Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptic activities, Blood, vol.93, pp.1668-1676, 1999.

Y. Tabe, M. Konopleva, and M. Munsell, PML-RAR?? is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival, Blood, vol.103, issue.5, pp.1815-1822, 2004.
DOI : 10.1182/blood-2003-03-0802

P. Cohen, Sweet's syndrome ??? a comprehensive review of an acute febrile neutrophilic dermatosis, Orphanet Journal of Rare Diseases, vol.2, issue.1, p.34, 2007.
DOI : 10.1186/1750-1172-2-34

Y. Lampl, Y. Eshel, and A. Kessler, Serum leptin level in women with idiopathic intracranial hypertension, Journal of Neurology, Neurosurgery & Psychiatry, vol.72, issue.5, pp.642-643, 2002.
DOI : 10.1136/jnnp.72.5.642

D. Thompson and K. Montarella, Drug-Induced Sweet's Syndrome, Annals of Pharmacotherapy, vol.42, issue.12, pp.802-811, 2007.
DOI : 10.1345/aph.1H563

A. Pollack, Handbook of essential drugs and regimens in hematological oncology, pp.33-34, 1991.